It was also documented that hENT2 protein expression significantly correlates with response of CLL cells to fludarabine ex vivo, potentially predicting therapeutic outcome in the clinical practice [74]. This evidence concerns the gene SLC29A2 and B-cell chronic lymphocytic leukemia.